A Health Service Research Study to Investigate Survival of Metastatic Pancreatic Cancer Patients After Sequential Chemotherapy
Stopped slow recruitment
Conditions
- Metastatic Pancreatic Ductal Adenocarcinoma
Interventions
- DRUG: OFF
- DRUG: FOLFIRI Protocol
Sponsor
AIO-Studien-gGmbH
Collaborators